Enzolytics Inc (ENZC)

[Valuator2]

Actually, the common stock A/S according to OTC Markets has been 3,900,000,000 since at least 8/1/23. I've got a picture of it. This is an example of the reasons I keep saying they need an internal CFO, assuming they want to file accurate reports (JMHO):
(1) the Balance sheet on page 28 of the 1Q 2024 report at 3/31/24 shows:

Common stock, $.0001 par value; 3,000,000,000 shares
authorized, 3,187,974,257 and 3,172,974,257 issued and
outstanding at March 31, 2024 and December 31, 2023,
respectively

(2) While on the same report on page 3, the narrative shows:

Trading symbol: ENZC PK
Exact title and class of securities outstanding: COMMON
CUSIP: 294112107
Par or stated value: 0.0001
Total shares authorized: 3,750,000,000 as of date: 3/31/2024
Total shares outstanding: 3,187,974,957 as of date: 3/31/2024
Total number of shareholders of record: 244 as of date: 3/31/2024

(3) Security Details page at OTC Markets shows:
Common stock A/S on 8/1/23 as 3,900,000,000 and still 3,900,000,000 on 1/19/24...both of which are prior to 3/31/24...
and again 3,900,000,000 as of 6/5/24.
https://www.otcmarkets.com/otcapi/company/financial-report/403184/content

So, I'm guessing OTC Markets will be the more authoritative source since its numbers are verified by the Transfer Agent, and that ENZC's numbers in some cases (not just the A/S example above) are prepared by outside accountants, who may not be fully/currently informed or attentive to details, and there is no qualified CFO internally to review (or better yet...to prepare) the reports, preferably a CPA since they are bound by ethics. This example is nitpicking, but I've seen more serious errors in reporting over the last 3 years or so. JMHO.